17040-20-9

Basic information

• Product Name: 4-Anilinobenzoic acid
• Synonyms: 4-Anilinobenzoic acid;p-Anilinobenzoic acid;4-(phenylamino)benzoic acid
• CAS NO: 17040-20-9
• Molecular Formula: C₁₃H₁₁NO₂
• Molecular Weight: 213.2319
• Mol File: 17040-20-9.mol
• Article Data: 13

Chemical Properties

• Boiling Point: 408.2°Cat760mmHg
• Flash Point: 200.7°C
• Appearance: /
• Density: 1.269g/cm³
• Vapor Pressure: 2.13E-07mmHg at 25°C
• Refractive Index: 1.667
• CAS DataBase Reference: 4-Anilinobenzoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 4-Anilinobenzoic acid(17040-20-9)
• EPA Substance Registry System: 4-Anilinobenzoic acid(17040-20-9)

Safety Data

• Hazardous Substances Data: 17040-20-9(Hazardous Substances Data)

Usage

General Description

4-Anilinobenzoic acid, also known as p-Aminobenzoic acid, is a chemical compound with the molecular formula C13H11NO2. It is a derivative of benzoic acid and aniline. 4-Anilinobenzoic acid is commonly used as a building block in the synthesis of various pharmaceuticals and dyes. In the pharmaceutical industry, 4-Anilinobenzoic acid is used in the production of sunscreen and local anesthetic preparations. Additionally, it is also used in the manufacturing of hair dyes and pigments due to its ability to absorb UV radiation. Moreover, it has been researched for its potential application in the treatment of various medical conditions such as depression and neuropathic pain.

InChI:InChI=1/C13H11NO2/c15-13(16)10-6-8-12(9-7-10)14-11-4-2-1-3-5-11/h1-9,14H,(H,15,16)

Upstream product

• 4058-18-8 methyl 4-(phenylamino)benzoate 
• 53451-87-9 phenyl(4-trifluoromethylphenyl)amine 
• 591-50-4 iodobenzene 
• 619-45-4 4-methoxycarbonyl aniline 
• 108-86-1 bromobenzene 
• 349-97-3 4-(trifluromethyl)acetanilide 
• 53451-85-7 N-phenyl-4-trifluoromethylacetanilide 
• 536-90-3 m-Anisidine 
• 12775-96-1 copper 
• 96-99-1 4-chloro-3-nitrobenzoate 
• 150-13-0 4-amino-benzoic acid 
• 108-90-7 chlorobenzene 
• 619-42-1 4-methoxycarbonylphenyl bromide 
• 62-53-3 aniline 

Downstream Products

• 4058-18-8 methyl 4-(phenylamino)benzoate 
• 64678-66-6 ethyl 4-(phenylamino)benzoate 
• 143667-39-4 4-anilino-benzoic acid hydrazide 
• 1382992-66-6 N-(2-(5-chloro-1H-indol-3-yl)ethyl)-4-(phenylamino)benzamide 
• 1377997-17-5 C₂₂H₂₉N₃O 

Relevant articles and documents

SEROTONIN 5-HT2B INHIBITORY COMPOUNDS

The compounds of the invention, as described herein, are novel serotonin 5-HT2B antagonists useful for the treatment of myxomatous mitral valve degeneration (MMVD), congestive heart failure (CHF), and/or asymptomatic heart failure in animals, preferably c

The synthesis of a [2.2]paracyclophane-derived secondary phosphine oxide and a study of its reactivity

A planar chiral secondary phosphine oxide based on [2.2]paracyclophane was synthesized and its chemistry investigated; it was shown to be a competent pre-ligand in palladium(0)-mediated reactions, and displayed promising activity in gold(I)-catalysed cyclisations. The secondary phosphine oxide could be transformed into a collection of P-stereogenic tertiary phosphine oxides. These are rare examples of the planar chirality of [2.2]paracyclophane being combined with a P-stereogenic centre. Unfortunately, epimerisation of the phosphorus stereocentre during reduction limits the use of this chemistry.

Bifunctional AKR1C3 inhibitors/androgen receptor modulators and methods of use thereof

The invention includes compositions comprising selective AKR1C3 inhibitors. The invention also includes compositions comprising bifunctional AKR1C3 inhibitors and selective androgen receptor modulators. The invention further includes methods of treatment using the compositions of the invention.